Xiuning Le, Zofia Piotrowska, Alexander I. Spira, Christina S. Baik, Maria Quintos Baggstrom, Gerald Steven Falchook, Joel W. Neal, Shirish M. Gadgeel, Gilberto Lopes, Melissa Lynne Johnson, Jonathan W. Riess, Danny Nguyen, Lisa Morelli, Danieska Sandino, Steven Margossian, Vivek Upadhyay, Fernando Santini. "NVL-330, a selective HER2 tyrosine kinase inhibitor, in patients with advanced or metastatic HER2-altered non-small cell lung cancer: The phase 1 HEROEX-1 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps8665